Clinical trials recruiting in Böblingen, Germany
10
Recruiting trials
15
Conditions
Phase breakdown
Phase 2 1Phase 3 6Not applicable 4
Conditions recruiting in Böblingen, Germany
Recruiting trials in Böblingen, Germany
- A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
- A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
- A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
- A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III)
- Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
- Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
- Praegnant Breast Cancer: Early/Advanced/Metastatic
- Register Schweres Asthma - German Asthma Net e.V.
- Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Common questions
How many clinical trials are recruiting in Böblingen, Germany?
10 recruiting trials have at least one study site in Böblingen, Germany.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.